1
|
Reshef Y, Sood L, Curtis M, Rumker L, Stein DJ, Palshikar MG, Nayar S, Filer A, Jonsson AH, Korsunsky I, Raychaudhuri S. Powerful and accurate case-control analysis of spatial molecular data with deep learning-defined tissue microniches. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2025:2025.02.07.637149. [PMID: 39975274 PMCID: PMC11839118 DOI: 10.1101/2025.02.07.637149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/21/2025]
Abstract
As spatial molecular data grow in scope and resolution, there is a pressing need to identify key spatial structures associated with disease. Current approaches often rely on hand-crafted features such as local abundances of manually annotated, discrete cell types, which may overlook important signals. Here we introduce variational inference-based microniche analysis (VIMA), a method that combines deep learning with principled statistics to discover associated spatial features with greater flexibility and precision. VIMA uses a variational autoencoder to extract numerical "fingerprints" from small tissue patches that capture their biological content. It uses these fingerprints to define a large number of "microniches" - small, potentially overlapping groups of tissue patches with highly similar biology that span multiple samples. It then uses rigorous statistics to identify microniches whose abundance correlates with case-control status. We show in simulations that VIMA is well calibrated and more powerful and accurate than other approaches. We then apply VIMA to a 140-gene spatial transcriptomics dataset in Alzheimer's dementia, a 54-marker CO-Detection by indEXing (CODEX) dataset in ulcerative colitis (UC), and a 7-marker immunohistochemistry dataset in rheumatoid arthritis (RA), in each case recapitulating known biology and identifying novel spatial features of disease.
Collapse
Affiliation(s)
- Yakir Reshef
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Lakshay Sood
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Michelle Curtis
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Laurie Rumker
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Daniel J. Stein
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Mukta G. Palshikar
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Saba Nayar
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and Department of Inflammation and Ageing, College of Medicine & Health, University of Birmingham, Birmingham, UK
- Birmingham Tissue Analytics, College of Medicine and Health, University of Birmingham, Birmingham, UK
| | - Andrew Filer
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and Department of Inflammation and Ageing, College of Medicine & Health, University of Birmingham, Birmingham, UK
| | - Anna Helena Jonsson
- University of Colorado Anschutz Medical Campus, Division of Rheumatology, Aurora, CO, USA
| | - Ilya Korsunsky
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| | - Soumya Raychaudhuri
- Center for Data Sciences, Brigham and Women’s Hospital, Boston, MA, USA
- Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
- Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
| |
Collapse
|
2
|
Rivens I, Jayadewa C, Mouratidis P, Ter Haar G. Histological characterization of HIFU lesions. Int J Hyperthermia 2024; 41:2389292. [PMID: 39134063 DOI: 10.1080/02656736.2024.2389292] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Revised: 06/17/2024] [Accepted: 08/01/2024] [Indexed: 05/21/2025] Open
Abstract
Background: High intensity focused ultrasound (HIFU) can destroy tissue by thermal ablation which may be accompanied by acoustic cavitation and/or tissue water boiling, but the biological and histological effects of these treatments have not been fully documented. Here, detailed histological analysis over time using well characterized HIFU exposures in in vivo rat livers is described. Methods: Exposures used invoked either (i) thermal, with acoustic cavitation and/or tissue water boiling or (ii) predominantly thermal damage. Cavitation activity was detected using both active and passive methods. Histological assessment involved hematoxylin and eosin (H&E), picrosirius red and immunohistochemical staining. Results: Distinct concentric damage regions were identified after HIFU exposures. The outermost ring showed a red H&E-stained rim that was characterized by hemorrhage. The adjacent inner band appeared white due to increased extracellular spaces. The morphology of the next zone depended on the exposure. Where there was no tissue acoustic cavitation/water boiling, this was the lesion center, in which heat-fixed cells were seen. Where acoustic cavitation/boiling occurred, a centermost zone with irregular holes up to several hundred microns across was seen. Cleaved caspase-3 and Hsp70 staining in the periphery of both types of HIFU exposures was seen within the outermost ring of hemorrhage, where an inflammatory response was also observed. By day 7, a distinct acellular region in the center of the HIFU lesions had been created. Conclusions: These results identify the morphological effects and elucidate the similarities and differences of HIFU-induced thermal lesions in the presence or absence of acoustic cavitation/tissue water boiling.
Collapse
Affiliation(s)
- Ian Rivens
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK
| | - Chaturika Jayadewa
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK
| | - Petros Mouratidis
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK
| | - Gail Ter Haar
- Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK
| |
Collapse
|
3
|
Lee S, Kim G, Lee J, Lee AC, Kwon S. Mapping cancer biology in space: applications and perspectives on spatial omics for oncology. Mol Cancer 2024; 23:26. [PMID: 38291400 PMCID: PMC10826015 DOI: 10.1186/s12943-024-01941-z] [Citation(s) in RCA: 16] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Accepted: 01/12/2024] [Indexed: 02/01/2024] Open
Abstract
Technologies to decipher cellular biology, such as bulk sequencing technologies and single-cell sequencing technologies, have greatly assisted novel findings in tumor biology. Recent findings in tumor biology suggest that tumors construct architectures that influence the underlying cancerous mechanisms. Increasing research has reported novel techniques to map the tissue in a spatial context or targeted sampling-based characterization and has introduced such technologies to solve oncology regarding tumor heterogeneity, tumor microenvironment, and spatially located biomarkers. In this study, we address spatial technologies that can delineate the omics profile in a spatial context, novel findings discovered via spatial technologies in oncology, and suggest perspectives regarding therapeutic approaches and further technological developments.
Collapse
Affiliation(s)
- Sumin Lee
- Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea
- Meteor Biotech,, Co. Ltd, Seoul, 08826, Republic of Korea
| | - Gyeongjun Kim
- Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea
| | - JinYoung Lee
- Division of Engineering Science, University of Toronto, Toronto, Ontario, ON, M5S 3H6, Canada
| | - Amos C Lee
- Meteor Biotech,, Co. Ltd, Seoul, 08826, Republic of Korea.
- Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea.
| | - Sunghoon Kwon
- Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
- Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.
- Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea.
- Institutes of Entrepreneurial BioConvergence, Seoul National University, Seoul, 08826, Republic of Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
| |
Collapse
|
4
|
Smith TD. Vespers and vampires: A lifelong microscopic search for the smallest of things. Anat Rec (Hoboken) 2023; 306:2670-2680. [PMID: 35202504 DOI: 10.1002/ar.24907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 02/15/2022] [Accepted: 02/15/2022] [Indexed: 11/11/2022]
Affiliation(s)
- Timothy D Smith
- School of Physical Therapy, Slippery Rock University, Slippery Rock, Pennsylvania, USA
| |
Collapse
|
5
|
Kanti MM, Striessnig-Bina I, Wieser BI, Schauer S, Leitinger G, Eichmann TO, Schweiger M, Winkler M, Winter E, Lana A, Kufferath I, Marsh LM, Kwapiszewska G, Zechner R, Hoefler G, Vesely PW. Adipose triglyceride lipase-mediated lipid catabolism is essential for bronchiolar regeneration. JCI Insight 2022; 7:e149438. [PMID: 35349484 PMCID: PMC9090255 DOI: 10.1172/jci.insight.149438] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Accepted: 03/23/2022] [Indexed: 01/18/2023] Open
Abstract
The lung airways are constantly exposed to inhaled toxic substances, resulting in cellular damage that is repaired by local expansion of resident bronchiolar epithelial club cells. Disturbed bronchiolar epithelial damage repair lies at the core of many prevalent lung diseases, including chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, and lung cancer. However, it is still not known how bronchiolar club cell energy metabolism contributes to this process. Here, we show that adipose triglyceride lipase (ATGL), the rate-limiting enzyme for intracellular lipolysis, is critical for normal club cell function in mice. Deletion of the gene encoding ATGL, Pnpla2 (also known as Atgl), induced substantial triglyceride accumulation, decreased mitochondrial numbers, and decreased mitochondrial respiration in club cells. This defect manifested as bronchiolar epithelial thickening and increased airway resistance under baseline conditions. After naphthalene‑induced epithelial denudation, a regenerative defect was apparent. Mechanistically, dysfunctional PPARα lipid-signaling underlies this phenotype because (a) ATGL was needed for PPARα lipid-signaling in regenerating bronchioles and (b) administration of the specific PPARα agonist WY14643 restored normal bronchiolar club cell ultrastructure and regenerative potential. Our data emphasize the importance of the cellular energy metabolism for lung epithelial regeneration and highlight the significance of ATGL-mediated lipid catabolism for lung health.
Collapse
Affiliation(s)
- Manu Manjunath Kanti
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- BioTechMed-Graz, Graz, Austria
| | - Isabelle Striessnig-Bina
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- BioTechMed-Graz, Graz, Austria
| | - Beatrix Irene Wieser
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- BioTechMed-Graz, Graz, Austria
| | - Silvia Schauer
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Gerd Leitinger
- BioTechMed-Graz, Graz, Austria
- Division of Cell Biology, Histology, and Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria
| | - Thomas O. Eichmann
- BioTechMed-Graz, Graz, Austria
- Institute of Molecular Biosciences, University of Graz, Graz, Austria
- Core Facility Mass Spectrometry, Medical University of Graz, Graz, Austria
| | - Martina Schweiger
- BioTechMed-Graz, Graz, Austria
- Institute of Molecular Biosciences, University of Graz, Graz, Austria
| | - Margit Winkler
- BioTechMed-Graz, Graz, Austria
- Institute of Molecular Biotechnology, NAWI Graz, Graz University of Technology, Graz, Austria
| | - Elke Winter
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Andrea Lana
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Iris Kufferath
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Leigh Matthew Marsh
- BioTechMed-Graz, Graz, Austria
- Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria
- Otto Loewi Research Center, Medical University of Graz, Graz, Austria
| | - Grazyna Kwapiszewska
- BioTechMed-Graz, Graz, Austria
- Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria
- Otto Loewi Research Center, Medical University of Graz, Graz, Austria
- Institute for Lung Health, Giessen, Germany
| | - Rudolf Zechner
- BioTechMed-Graz, Graz, Austria
- Institute of Molecular Biosciences, University of Graz, Graz, Austria
| | - Gerald Hoefler
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- BioTechMed-Graz, Graz, Austria
| | - Paul Willibald Vesely
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- BioTechMed-Graz, Graz, Austria
| |
Collapse
|
6
|
Xie H, Heier C, Meng X, Bakiri L, Pototschnig I, Tang Z, Schauer S, Baumgartner VJ, Grabner GF, Schabbauer G, Wolinski H, Robertson GR, Hoefler G, Zeng W, Wagner EF, Schweiger M, Zechner R. An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia. Proc Natl Acad Sci U S A 2022; 119:e2112840119. [PMID: 35210363 PMCID: PMC8892347 DOI: 10.1073/pnas.2112840119] [Citation(s) in RCA: 45] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 01/11/2022] [Indexed: 02/07/2023] Open
Abstract
Cancer-associated cachexia (CAC) is a hypermetabolic syndrome characterized by unintended weight loss due to the atrophy of adipose tissue and skeletal muscle. A phenotypic switch from white to beige adipocytes, a phenomenon called browning, accelerates CAC by increasing the dissipation of energy as heat. Addressing the mechanisms of white adipose tissue (WAT) browning in CAC, we now show that cachexigenic tumors activate type 2 immunity in cachectic WAT, generating a neuroprotective environment that increases peripheral sympathetic activity. Increased sympathetic activation, in turn, results in increased neuronal catecholamine synthesis and secretion, β-adrenergic activation of adipocytes, and induction of WAT browning. Two genetic mouse models validated this progression of events. 1) Interleukin-4 receptor deficiency impeded the alternative activation of macrophages, reduced sympathetic activity, and restrained WAT browning, and 2) reduced catecholamine synthesis in peripheral dopamine β-hydroxylase (DBH)-deficient mice prevented cancer-induced WAT browning and adipose atrophy. Targeting the intraadipose macrophage-sympathetic neuron cross-talk represents a promising therapeutic approach to ameliorate cachexia in cancer patients.
Collapse
Affiliation(s)
- Hao Xie
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria
| | - Christoph Heier
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria
| | - Xia Meng
- School of Medicine, Tsinghua University, 100190 Beijing, China
| | - Latifa Bakiri
- Genes and Disease Group, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria
| | | | - Zhiyuan Tang
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria
- Department of Pharmacy, Affiliated Hospital of Nantong University, 226001 Nantong, China
| | - Silvia Schauer
- Diagnostic and Research Institute of Pathology, Medical University Graz, 8010 Graz, Austria
| | | | - Gernot F Grabner
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria
| | - Gernot Schabbauer
- Institute of Physiology, Medical University of Vienna, 1090 Vienna, Austria
| | - Heimo Wolinski
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria
| | | | - Gerald Hoefler
- Diagnostic and Research Institute of Pathology, Medical University Graz, 8010 Graz, Austria
| | - Wenwen Zeng
- School of Medicine, Tsinghua University, 100190 Beijing, China
| | - Erwin F Wagner
- Genes and Disease Group, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria
- Genes and Disease Group, Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria
| | - Martina Schweiger
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria;
- Field of Excellence BioHealth, University of Graz, 8010 Graz, Austria
- BioTechMed-Graz, 8010 Graz, Austria
| | - Rudolf Zechner
- Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria;
- Field of Excellence BioHealth, University of Graz, 8010 Graz, Austria
- BioTechMed-Graz, 8010 Graz, Austria
| |
Collapse
|
7
|
Ogawa K, Ishii Y, Toyoda T. [Role and potential of histopathological specimens in the toxicological evaluation of pharmaceuticals and chemicals]. Nihon Yakurigaku Zasshi 2022; 157:139-145. [PMID: 35228447 DOI: 10.1254/fpj.21102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
With the development of molecular-targeted drugs, the demand for utilization of histopathological specimens and pathological diagnosis is increasing in the field of clinical pathology. In particular, in case of companion diagnostics, the results of immunohistochemical staining have become beyond diagnostic assistance, definitive diagnosis, and now indispensable for selection of therapeutic agents. Histopathological examination also serves an important role in non-clinical toxicological evaluation. Particularly, it is pivotal for obtaining data on organ-specific toxicity and carcinogenicity. On the other hand, a weight of evidence approach is currently being considered in International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) S1 as an option to replace the 2-year rat carcinogenicity study, in which case the evaluation of the 26-week-repeated dose toxicity study will be more important. In this article, We would like to introduce the usefulness of γ-H2AX-based rat bladder carcinogenicity evaluation using histopathological specimens obtain from 28-day repeated-dose study and the application of mass spectrometric imaging currently under consideration in our laboratory, thus discuss the role of histopathological examination in non-clinical toxicological and safety evaluation and its future perspective.
Collapse
Affiliation(s)
- Kumiko Ogawa
- Division of Pathology, National Institute of Health Sciences
| | - Yuji Ishii
- Division of Pathology, National Institute of Health Sciences
| | - Takeshi Toyoda
- Division of Pathology, National Institute of Health Sciences
| |
Collapse
|
8
|
Brazilin: Biological activities and therapeutic potential in chronic degenerative diseases and cancer. Pharmacol Res 2021; 175:106023. [PMID: 34883212 DOI: 10.1016/j.phrs.2021.106023] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/03/2021] [Revised: 11/17/2021] [Accepted: 12/03/2021] [Indexed: 12/26/2022]
Abstract
Caesalpinia sappan and Haematoxylum brasiletto belong to the Fabaceae family, predominantly distributed in Southeast Asia and America. The isoflavonoid brazilin has been identified from the bark and heartwood of these plants. This review summarizes the studies describing the biological activities of these plants and brazilin. Mainly, brazilin protects cells from oxidative stress, shows anti-inflammatory and antibacterial properties, and hypoglycemic effect. In addition, it has a biological impact on various pathologies such as Alzheimer's disease, Parkinson's disease, fibrillogenesis, and osteoarthritis. Interestingly, most of the antecedents are related to the anticancer effect of brazilin. In several cancers such as osteosarcoma, neuroblastoma, multiple myeloma, glioblastoma, bladder, melanoma, breast, tongue, colon, cervical, head, and neck squamous cell carcinoma, brazilin induces autophagy by increasing the levels of the LC3-II protein. Furthermore, it inhibits cell proliferation and induces apoptosis through increased expression of Bcl-2, Bcl-XL, p21, p27, activation of caspase-3 and -7, and the cleavage of PARP and inhibiting the expression of Bax. In addition, it blocks the expression of JNK and regulates the nuclear translocation of Nrf2. Together, these data positions brazilin as a compound of natural origin with multiple bioactivities and therapeutic potential in various chronic degenerative diseases and cancer.
Collapse
|
9
|
Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research. Alzheimers Dement 2021; 17:1554-1574. [PMID: 33797838 PMCID: PMC8478697 DOI: 10.1002/alz.12321] [Citation(s) in RCA: 174] [Impact Index Per Article: 43.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2020] [Revised: 01/11/2021] [Accepted: 02/03/2021] [Indexed: 12/29/2022]
Abstract
Neurofibrillary tangles, one of the neuropathologic hallmarks of Alzheimer's disease, have a dynamic lifespan of maturity that associates with progressive neuronal dysfunction and cognitive deficits. As neurofibrillary tangles mature, the biology of the neuron undergoes extensive changes that may impact biomarker recognition and therapeutic targeting. Neurofibrillary tangle maturity encompasses three levels: pretangles, mature tangles, and ghost tangles. In this review, we detail distinct and overlapping characteristics observed in the human brain regarding morphologic changes the neuron undergoes, conversion from intracellular to extracellular space, tau immunostaining patterns, and tau isoform expression changes across the lifespan of the neurofibrillary tangle. Post-translational modifications of tau such as phosphorylation, ubiquitination, conformational events, and truncations are discussed to contextualize tau immunostaining patterns. We summarize accumulated and emerging knowledge of neurofibrillary tangle maturity, discuss the current tools used to interpret the dynamic nature in the postmortem brain, and consider implications for cognitive dysfunction and tau biomarkers.
Collapse
Affiliation(s)
| | - Val J. Lowe
- Department of RadiologyMayo ClinicRochesterMinnesotaUSA
| | | |
Collapse
|
10
|
Henwood AF. Comment on "Digital mucous cyst: Altered epidermal mucin as a clue to diagnosis". J Cutan Pathol 2021; 48:603-604. [PMID: 33438801 DOI: 10.1111/cup.13959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Revised: 12/31/2020] [Accepted: 01/10/2021] [Indexed: 11/28/2022]
Affiliation(s)
- Anthony F Henwood
- Histopathology Department, The Children's Hospital at Westmead, Sydney, Australia.,School of Medicine, University of Western Sydney, Sydney, Australia
| |
Collapse
|
11
|
Abstract
Aβ plaques are one of the two lesions in the brain that define the neuropathological diagnosis of Alzheimer's disease. Plaques are highly diverse structures; many of them include massed, fibrillar polymers of the Aβ protein referred to as Aβ-amyloid, but some lack the defining features of amyloid. Cellular elements in 'classical' plaques include abnormal neuronal processes and reactive glial cells, but these are not present in all plaques. Plaques have been given various names since their discovery in 1892, including senile plaques, amyloid plaques, and neuritic plaques. However, with the identification in the 1980s of Aβ as the obligatory and universal component of plaques, the term 'Aβ plaques' has become a unifying term for these heterogeneous formations. Tauopathy, the second essential lesion of the Alzheimer's disease diagnostic dyad, is downstream of Aβ-proteopathy, but it is critically important for the manifestation of dementia. The etiologic link between Aβ-proteopathy and tauopathy in Alzheimer's disease remains largely undefined. Aβ plaques develop and propagate via the misfolding, self-assembly and spread of Aβ by the prion-like mechanism of seeded protein aggregation. Partially overlapping sets of risk factors and sequelae, including inflammation, genetic variations, and various environmental triggers have been linked to plaque development and idiopathic Alzheimer's disease, but no single factor has emerged as a requisite cause. The value of Aβ plaques per se as therapeutic targets is uncertain; although some plaques are sites of focal gliosis and inflammation, the complexity of inflammatory biology presents challenges to glia-directed intervention. Small, soluble, oligomeric assemblies of Aβ are enriched in the vicinity of plaques, and these probably contribute to the toxic impact of Aβ aggregation on the brain. Measures designed to reduce the production or seeded self-assembly of Aβ can impede the formation of Aβ plaques and oligomers, along with their accompanying abnormalities; given the apparent long timecourse of the emergence, maturation and proliferation of Aβ plaques in humans, such therapies are likely to be most effective when begun early in the pathogenic process, before significant damage has been done to the brain. Since their discovery in the late 19th century, Aβ plaques have, time and again, illuminated fundamental mechanisms driving neurodegeneration, and they should remain at the forefront of efforts to understand, and therefore treat, Alzheimer's disease.
Collapse
Affiliation(s)
- Lary C. Walker
- Department of Neurology and Yerkes National Primate Research Center, Emory University
| |
Collapse
|
12
|
Xie H, Heier C, Kien B, Vesely PW, Tang Z, Sexl V, Schoiswohl G, Strießnig-Bina I, Hoefler G, Zechner R, Schweiger M. Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling. Biochim Biophys Acta Mol Cell Biol Lipids 2020; 1865:158737. [PMID: 32404277 PMCID: PMC7397471 DOI: 10.1016/j.bbalip.2020.158737] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2019] [Revised: 04/15/2020] [Accepted: 05/06/2020] [Indexed: 12/25/2022]
Abstract
Aberrant fatty acid (FA) metabolism is a hallmark of proliferating cells, including untransformed fibroblasts or cancer cells. Lipolysis of intracellular triglyceride (TG) stores by adipose triglyceride lipase (ATGL) provides an important source of FAs serving as energy substrates, signaling molecules, and precursors for membrane lipids. To investigate if ATGL-mediated lipolysis impacts cell proliferation, we modified ATGL activity in murine embryonic fibroblasts (MEFs) and in five different cancer cell lines to determine the consequences on cell growth and metabolism. Genetic or pharmacological inhibition of ATGL in MEFs causes impaired FA oxidation, decreased ROS production, and a substrate switch from FA to glucose leading to decreased AMPK-mTOR signaling and higher cell proliferation rates. ATGL expression in these cancer cells is low when compared to MEFs. Additional ATGL knockdown in cancer cells did not significantly affect cellular lipid metabolism or cell proliferation whereas the ectopic overexpression of ATGL increased lipolysis and reduced proliferation. In contrast to ATGL silencing, pharmacological inhibition of ATGL by Atglistatin© impeded the proliferation of diverse cancer cell lines, which points at an ATGL-independent effect. Our data indicate a crucial role of ATGL-mediated lipolysis in the regulation of cell proliferation. The observed low ATGL activity in cancer cells may represent an evolutionary selection process and mechanism to sustain high cell proliferation rates. As the increasing ATGL activity decelerates proliferation of five different cancer cell lines this may represent a novel therapeutic strategy to counteract uncontrolled cell growth.
Collapse
Affiliation(s)
- Hao Xie
- Institute of Molecular Biosciences, University of Graz, Graz 8010, Austria
| | - Christoph Heier
- Institute of Molecular Biosciences, University of Graz, Graz 8010, Austria
| | - Benedikt Kien
- Institute of Molecular Biosciences, University of Graz, Graz 8010, Austria
| | - Paul W Vesely
- Institute of Pathology, Medical University of Graz, Graz 8010, Austria
| | - Zhiyuan Tang
- Department of Pharmacy, Affiliated Hospital of Nantong University, Nantong 226001, China
| | - Veronika Sexl
- Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna 1210, Austria
| | | | | | - Gerald Hoefler
- Institute of Pathology, Medical University of Graz, Graz 8010, Austria
| | - Rudolf Zechner
- Institute of Molecular Biosciences, University of Graz, Graz 8010, Austria; BioTechMed-Graz, Mozartgasse 12/II, Graz 8010, Austria.
| | - Martina Schweiger
- Institute of Molecular Biosciences, University of Graz, Graz 8010, Austria.
| |
Collapse
|
13
|
Carvalho CL, Abade dos Santos FA, Monteiro M, Carvalho P, Mendonça P, Duarte MD. First cases of myxomatosis in Iberian hares (
Lepus granatensis
) in Portugal. VETERINARY RECORD CASE REPORTS 2020. [DOI: 10.1136/vetreccr-2019-001044] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- Carina Luísa Carvalho
- Instituto Nacional de Investigação Agrária e VeterináriaVirology LaboratoryAv. da República, Quinta do Marquês (edifício sede)OeirasPortugal
| | - Fábio Alexandre Abade dos Santos
- Instituto Nacional de Investigação Agrária e VeterináriaVirology LaboratoryAv. da República, Quinta do Marquês (edifício sede)OeirasPortugal
- Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA)Faculdade de Medicina VeterináriaUniversidadede LisboaAvenida da Universidade TécnicaLisboaPortugal
| | - Madelena Monteiro
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV)Pathology LaboratoryAv. da República, Quinta do Marquês (edifício sede)OeirasPortugal
| | - Paulo Carvalho
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV)Pathology LaboratoryAv. da República, Quinta do Marquês (edifício sede)OeirasPortugal
| | - Paula Mendonça
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV)Pathology LaboratoryAv. da República, Quinta do Marquês (edifício sede)OeirasPortugal
| | - Margarida Dias Duarte
- Instituto Nacional de Investigação Agrária e VeterináriaVirology LaboratoryAv. da República, Quinta do Marquês (edifício sede)OeirasPortugal
- Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA)Faculdade de Medicina VeterináriaUniversidadede LisboaAvenida da Universidade TécnicaLisboaPortugal
| |
Collapse
|
14
|
Carvalho CL, Abade dos Santos FA, Fagulha T, Carvalho P, Mendonça P, Monteiro M, Dias Duarte M. Myxoma virus and rabbit haemorrhagic disease virus 2 coinfection in a European wild rabbit (
Oryctolagus cuniculus algirus
), Portugal. VETERINARY RECORD CASE REPORTS 2020. [DOI: 10.1136/vetreccr-2019-001002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- Carina Luisa Carvalho
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
| | - Fábio Alexandre Abade dos Santos
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
- CIISAFaculdade de Medicina VeterináriaUniversidade de LisboaAvenida da Universidade TécnicaLisboaPortugal
| | - Teresa Fagulha
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
| | - Paulo Carvalho
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
| | - Paula Mendonça
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
| | - Madalena Monteiro
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
| | - Margarida Dias Duarte
- Instituto Nacional de Investigação Agrária e veterinária (INIAV)Av. da República, Quinta do Marquês (edíficio sede)OeirasPortugal
- CIISAFaculdade de Medicina VeterináriaUniversidade de LisboaAvenida da Universidade TécnicaLisboaPortugal
| |
Collapse
|
15
|
Pereira RM, Oliveira DG, Costa FEDC, Mundim FGL, Mendonça ARDA. Applicability of eucalyptus wood waste extracts for the histological staining of connective tissue. J Histotechnol 2019; 43:83-89. [PMID: 31665982 DOI: 10.1080/01478885.2019.1683125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Biological staining of tissue is a crucial procedure in histotechnology. Rudimentary methods for section preparation have often used stains from natural products, although use of synthetic dyes has become the contemporary standard. Artificial dyes increase the operating costs of a laboratory as well as increase the environmental and personnel risks during manufacturing and usage. These considerations have stimulated research to find alternative natural stains from the wide diversity of plant species. The present study investigated the effect of Eucalyptus sp. (Myrtaceae) wood waste extract on histological staining of animal tissues, using a series of pigment concentrations, pH conditions, and temperatures. Eucalyptus wooden slivers were dried, milled, and 1 g, 2 g, and 4 g of the fine powder was subjected to 50% ethanol extraction for 2 days. Staining tests were then performed on formalin fixed paraffin embedded (FFPE) sections. Increasing acetic acid concentrations (1%, 2% and 4%) were added to the extracts and compared to an acid-free extract. Staining was performed at both ambient room temperature (RT) and 60°C. Connective tissue acidophilic components were well-contrasted and a hematoxylin counterstain demonstrated distinct structural differences between matrix and cell nuclei. Therefore, the present findings demonstrate the potential utility of the eucalyptus wood extracts application as a natural stain alternative for routine histology.
Collapse
Affiliation(s)
| | | | | | - Fiorita Gonzales Lopes Mundim
- Biological Sciences Department, Vale do Sapucai University , Pouso Alegre, Brazil.,Pathology Laboratory, Samuel Libanio Clinical Hospital , Pouso Alegre, Brazil
| | | |
Collapse
|
16
|
Zhang X, Li D, Huang J, Ou K, Yan B, Shi F, Zhang J, Zhang J, Pang J, Kang Y, Wu J. Screening of pH-responsive long-circulating polysaccharide–drug conjugate nanocarriers for antitumor applications. J Mater Chem B 2019; 7:251-264. [PMID: 32254550 DOI: 10.1039/c8tb02474j] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Schematic illustration of the development of long-circulating pH-responsive polysaccharide–DOX prodrug nanoparticles for antitumor applications.
Collapse
|
17
|
Ortiz-Hidalgo C, Pina-Oviedo S. Hematoxylin: Mesoamerica’s Gift to Histopathology. Palo de Campeche (Logwood Tree), Pirates’ Most Desired Treasure, and Irreplaceable Tissue Stain. Int J Surg Pathol 2018; 27:4-14. [DOI: 10.1177/1066896918787652] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Hematoxylin is a basic dye derived from the heartwood of Palo de Campeche ( Haematoxylum campechianum), the logwood tree native to Mexico and Central America. Haematoxylum means “bloodwood” in reference to its dark-red heartwood and campechianum refers to its site of origin, the coastal city of Campeche on the Yucatan Peninsula, Mexico. Hematoxylin is colorless but it turns into the color dye hematein after oxidation (ripening). The dyeing property of logwood was well-known to the natives of the Yucatan Peninsula before the arrival of the Spaniards who brought it to Europe shortly after the discovery of the Americas. An important trade soon developed related to growing and preparing hematoxylin for dyeing fabrics. Pirates discovered that one shipload of logwood was equivalent to a year’s value from any other cargo, and by 1563, more than 400 pirate vessels wandered the Atlantic Ocean and attacked Spanish galleons transporting gold, silver, and logwood from the Americas to Europe. Hematoxylin and eosin is a staining method that dates back to the late 19th century. In 1865 and 1891, Böhmer and Meyer, respectively, first used hematoxylin in combination with a mordant (alum). Later, with the use of anilines by Ehrlich, the repertoire of stains expanded rapidly resulting in the microscopic descriptions of multiple diseases that were defined by their stainable features. Today hematoxylin, along with eosin, remains the most popular stain in histology.
Collapse
Affiliation(s)
- Carlos Ortiz-Hidalgo
- Hospital y Fundación Médica Sur, Mexico City, Mexico
- Universidad Panamericana, Mexico City, Mexico
| | | |
Collapse
|
18
|
Affiliation(s)
- GE Orchard
- Viapath Analytics, Histopathology Department, St John’s Institute of Dermatology, St. Thomas’ Hospital , London, UK
| |
Collapse
|
19
|
Cooksey CJ. Quirks of dye nomenclature. 10. Eosin Y and its close relatives. Biotech Histochem 2018; 93:211-219. [DOI: 10.1080/10520295.2017.1413207] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Affiliation(s)
- CJ Cooksey
- Independent Scholar, Watford, United Kingdom
| |
Collapse
|
20
|
Rehman FU, Jiang H, Selke M, Wang X. Mammalian cells: a unique scaffold forin situbiosynthesis of metallic nanomaterials and biomedical applications. J Mater Chem B 2018; 6:6501-6514. [DOI: 10.1039/c8tb01955j] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Nanoscale materials biosynthesis by using mammalian scaffold is green and highly biocompatible.
Collapse
Affiliation(s)
- Fawad Ur Rehman
- State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University
- Nanjing 210096
- People's Republic of China
- International Joint Center for Biomedical Innovation, Henan University
- Kaifeng
| | - Hui Jiang
- State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University
- Nanjing 210096
- People's Republic of China
| | - Matthias Selke
- Department of Chemistry and Biochemistry, California State University
- Los Angeles
- USA
| | - Xuemei Wang
- State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University
- Nanjing 210096
- People's Republic of China
| |
Collapse
|
21
|
Carvalho CL, Silva S, Gouveia P, Costa M, Duarte EL, Henriques AM, Barros SS, Luís T, Ramos F, Fagulha T, Fevereiro M, Duarte MD. Emergence of rabbit haemorrhagic disease virus 2 in the archipelago of Madeira, Portugal (2016-2017). Virus Genes 2017. [PMID: 28639220 DOI: 10.1007/s11262-017-1483-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
We report the detection of rabbit haemorrhagic disease virus 2 (RHDV2) in the Madeira archipelago, Portugal. Viral circulation was confirmed by RT-qPCR and vp60 sequencing. Epidemiological data revealed the outbreak initiated in October 2016 in Porto Santo affecting wild and domestic rabbits. It was then detected three months later on the island of Madeira. Five haplotypes were identified and a genetic overall similarity of 99.54 to 99.89% was observed between the two viral populations. Unique single nucleotide polymorphisms were recognised in the Madeira archipelago strains, two of which resulting in amino acid substitutions at positions 480 and 570 in the VP60 protein. Phylogenetic investigation by Maximum Likelihood showed all the vp60 sequences from the Madeira archipelago group together with high bootstraps. The analysis also showed that the Madeira archipelago strains are closely related to the strains detected in the south of mainland Portugal in 2016, suggesting a possible introduction from the mainland. The epidemiological data and high genetic similarity indicate a common source for the Porto Santo and Madeira RHDV2 outbreaks. Human activity related to hunting was most probably at the origin of the Madeira outbreak.
Collapse
Affiliation(s)
- Carina Luísa Carvalho
- Instituto de Ciências Agrárias e Ambientais Mediterrânicas (ICAAM), Universidade de Évora, Núcleo da Mitra, 7000, Évora, Portugal
- Instituto de Investigação e Formação Avançada (IIFA), Universidade de Évora, Núcleo da Mitra, 7000, Évora, Portugal
| | - Sara Silva
- Direção Regional para a Administração Pública do Porto Santo (DRAPS), Avenida Vieira de Castro, nº1, 9400-179, Porto Santo, Portugal
| | - Paz Gouveia
- Laboratório Regional de Veterinária e Segurança Alimentar, Direção Regional de Agricultura (DRA) da Região Autónoma da Madeira, Caminho das Quebradas de Baixo, nº 79, S. Martinho, 9000-233, Funchal, Madeira, Portugal
| | - Margarida Costa
- Laboratório Regional de Veterinária e Segurança Alimentar, Direção Regional de Agricultura (DRA) da Região Autónoma da Madeira, Caminho das Quebradas de Baixo, nº 79, S. Martinho, 9000-233, Funchal, Madeira, Portugal
| | - Elsa Leclerc Duarte
- Instituto de Ciências Agrárias e Ambientais Mediterrânicas (ICAAM), Universidade de Évora, Núcleo da Mitra, 7000, Évora, Portugal
- Instituto de Investigação e Formação Avançada (IIFA), Universidade de Évora, Núcleo da Mitra, 7000, Évora, Portugal
- Departamento de Medicina Veterinária, Universidade de Évora, Núcleo da Mitra, 7000, Évora, Portugal
| | - Ana Margarida Henriques
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal
| | - Sílvia Santos Barros
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal
| | - Tiago Luís
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal
| | - Fernanda Ramos
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal
| | - Teresa Fagulha
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal
| | - Miguel Fevereiro
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal
| | - Margarida Dias Duarte
- Laboratório de Virologia, Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Av. da República, Quinta do Marquês, 2780-157, Oeiras, Portugal.
| |
Collapse
|
22
|
Carvalho C, Duarte E, Monteiro J, Afonso C, Pacheco J, Carvalho P, Mendonça P, Botelho A, Albuquerque T, Themudo P, Fevereiro M, Henriques A, Santos Barros S, Dias Duarte M. Progression of rabbit haemorrhagic disease virus 2 upon vaccination in an industrial rabbitry: a laboratorial approach. WORLD RABBIT SCIENCE 2017. [DOI: 10.4995/wrs.2017.5708] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
<p>Rabbit haemorrhagic disease virus 2 (RHDV2) emerged recently in several European countries, leading to extensive economic losses in the industry. In response to this new infection, specific inactivated vaccines were developed in Europe and full and rapid setup of protective immunity induced by vaccination was reported. However, data on the efficacy of these vaccines in an ongoing-infection scenario is unavailable. In this study we investigated an infected RHDV2 indoor industrial meat rabbitry, where fatalities continued to occur after the implementation of the RHDV2 vaccination, introduced to control the disease. The aim of this study was to understand if these mortalities were RHDV2-related, to discover if the dead animals showed any common features such as age or time distance from vaccination, and to identify the source of the outbreak. Anatomo-pathological analysis of vaccinated animals with the virus showed lesions compatible with systemic haemorrhagic disease and RHDV2-RNA was detected in 85.7% of the animals tested. Sequencing of the <em>vp60</em> gene amplified from liver samples led to the recognition of RHDV2 field strains demonstrating that after the implementation of vaccination, RHDV2 continued to circulate in the premises and to cause sporadic deaths. A nearby, semi-intensive, RHDV2 infected farm belonging to the same owner was identified as the most probable source of the virus. The main risk factors for virus introduction in these two industries were identified. Despite the virus being able to infect a few of the vaccinated rabbits, the significant decrease in mortality rate observed in vaccinated adult rabbits clearly reflects the efficacy of the vaccination. Nonetheless, the time taken to control the infection also highlights the importance of RHDV2 vaccination prior to the first contact with the virus, highly recommendable in endemic areas, to mitigate the infection’s impact on the industry.</p>
Collapse
|
23
|
Challenges in the rabbit haemorrhagic disease 2 (RHDV2) molecular diagnosis of vaccinated rabbits. Vet Microbiol 2017; 198:43-50. [DOI: 10.1016/j.vetmic.2016.12.006] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2016] [Revised: 11/29/2016] [Accepted: 12/03/2016] [Indexed: 12/13/2022]
|
24
|
Al-Zoughbi W, Pichler M, Gorkiewicz G, Guertl-Lackner B, Haybaeck J, Jahn SW, Lackner C, Liegl-Atzwanger B, Popper H, Schauer S, Nusshold E, Kindt ASD, Trajanoski Z, Speicher MR, Haemmerle G, Zimmermann R, Zechner R, Vesely PW, Hoefler G. Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia. Oncotarget 2016; 7:33832-40. [PMID: 27213586 PMCID: PMC5085122 DOI: 10.18632/oncotarget.9418] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2015] [Accepted: 04/02/2016] [Indexed: 01/22/2023] Open
Abstract
Metabolic reprogramming is a hallmark of cancer. Understanding cancer metabolism is instrumental to devise innovative therapeutic approaches. Anabolic metabolism, including the induction of lipogenic enzymes, is a key feature of proliferating cells. Here, we report a novel tumor suppressive function for adipose triglyceride lipase (ATGL), the rate limiting enzyme in the triglyceride hydrolysis cascade.In immunohistochemical analysis, non-small cell lung cancers, pancreatic adenocarcinoma as well as leiomyosarcoma showed significantly reduced levels of ATGL protein compared to corresponding normal tissues. The ATGL gene was frequently deleted in various forms of cancers. Low levels of ATGL mRNA correlated with significantly reduced survival in patients with ovarian, breast, gastric and non-small cell lung cancers. Remarkably, pulmonary neoplasia including invasive adenocarcinoma developed spontaneously in mice lacking ATGL pointing to an important role for this lipase in controlling tumor development.Loss of ATGL, as detected in several forms of human cancer, induces spontaneous development of pulmonary neoplasia in a mouse model. Our results, therefore, suggest a novel tumor suppressor function for ATGL and contribute to the understanding of cancer metabolism. We propose to evaluate loss of ATGL protein expression for the diagnosis of malignant tumors. Finally, modulation of the lipolytic pathway may represent a novel therapeutic approach in the treatment of human cancer.
Collapse
MESH Headings
- Adenocarcinoma/enzymology
- Adenocarcinoma/genetics
- Adenocarcinoma/pathology
- Adenocarcinoma of Lung
- Animals
- Biomarkers, Tumor/analysis
- Biomarkers, Tumor/genetics
- Cell Transformation, Neoplastic/genetics
- Cell Transformation, Neoplastic/metabolism
- Cell Transformation, Neoplastic/pathology
- Computational Biology
- Data Mining
- Databases, Genetic
- Down-Regulation
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Genetic Predisposition to Disease
- Humans
- Lipase/analysis
- Lipase/deficiency
- Lipase/genetics
- Lipolysis
- Lung Neoplasms/enzymology
- Lung Neoplasms/genetics
- Lung Neoplasms/pathology
- Mice, Inbred C57BL
- Mice, Knockout
- Neoplasms/enzymology
- Neoplasms/genetics
- Neoplasms/pathology
- Phenotype
Collapse
Affiliation(s)
- Wael Al-Zoughbi
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Martin Pichler
- Division of Oncology, Medical University of Graz, Graz, Austria
| | | | | | | | - Stephan W. Jahn
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Carolin Lackner
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | | | - Helmut Popper
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Silvia Schauer
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Elisa Nusshold
- Institute of Pathology, Medical University of Graz, Graz, Austria
| | - Alida S. D. Kindt
- Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
| | - Zlatko Trajanoski
- Biocenter, Division of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria
| | | | | | - Robert Zimmermann
- Institute of Molecular Biosciences, University of Graz, Graz, Austria
| | - Rudolf Zechner
- Institute of Molecular Biosciences, University of Graz, Graz, Austria
| | - Paul W. Vesely
- Institute of Pathology, Medical University of Graz, Graz, Austria
- Institute of Molecular Biosciences, University of Graz, Graz, Austria
| | - Gerald Hoefler
- Institute of Pathology, Medical University of Graz, Graz, Austria
| |
Collapse
|
25
|
Cao Y, Yang X, Wu Y, Yi J, Wu Y, Yu C, Huang Y, Bao Y, Sun L, Li Y. Dual release of angiostatin and curcumin from biodegradable PLGA microspheres inhibit Lewis lung cancer in a mice model. RSC Adv 2016. [DOI: 10.1039/c6ra23627h] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Schematic illustration of the proposed structure and mechanism of anti-cancer actions of As–Cur–PLGA-Ms.
Collapse
Affiliation(s)
- Yue Cao
- National Engineering Laboratory for Druggable Gene and Protein Screening
- Northeast Normal University
- Changchun 130117
- P. R. China
| | - Xiaoguang Yang
- National Engineering Laboratory for Druggable Gene and Protein Screening
- Northeast Normal University
- Changchun 130117
- P. R. China
| | - Yannan Wu
- School of Life Sciences
- Northeast Normal University
- Changchun 130024
- P. R. China
| | - Jingwen Yi
- National Engineering Laboratory for Druggable Gene and Protein Screening
- Northeast Normal University
- Changchun 130117
- P. R. China
| | - Yin Wu
- School of Life Sciences
- Northeast Normal University
- Changchun 130024
- P. R. China
| | - Chunlei Yu
- School of Life Sciences
- Northeast Normal University
- Changchun 130024
- P. R. China
| | - Yanxin Huang
- Institute of Genetics and Cytology
- Northeast Normal University
- Changchun 130024
- P. R. China
| | - Yongli Bao
- School of Life Sciences
- Northeast Normal University
- Changchun 130024
- P. R. China
| | - Luguo Sun
- Institute of Genetics and Cytology
- Northeast Normal University
- Changchun 130024
- P. R. China
| | - Yuxin Li
- National Engineering Laboratory for Druggable Gene and Protein Screening
- Northeast Normal University
- Changchun 130117
- P. R. China
| |
Collapse
|
26
|
Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S, Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett C, Karp D, Kurzrock R, Zinner R, Raghav K, Subbiah V, Hess K, Meric-Bernstam F, Hong DS, Overman MJ. Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response. BMC Cancer 2015; 15:713. [PMID: 26474549 PMCID: PMC4609167 DOI: 10.1186/s12885-015-1701-3] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2015] [Accepted: 10/07/2015] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND This retrospective study aims to investigate the activity of retreatment with anti-EGFR-based therapies in order to explore the concept of clonal evolution by evaluating the impact of prior activity and intervening time interval. METHODS Eighty-nine KRAS exon 2-wild-type metastatic colorectal patients were retreated on phase I/II clinical trials containing anti-EGFR therapies after progressing on prior cetuximab or panitumumab. Response on prior anti-EGFR therapy was defined retrospectively per physician-records as response or stable disease ≥6 months. Multivariable statistical methods included a multiple logistic regression model for response, and Cox proportional hazards model for progression-free survival. RESULTS Retreatment anti-EGFR agents were cetuximab (n = 76) or cetuximab plus erlotinib (n = 13). The median interval time between prior and retreatment regimens was 4.57 months (range: 0.46-58.7). Patients who responded to the prior cetuximab or panitumumab were more likely to obtain clinical benefit to the retreatment compared to the non-responders in both univariate (p = 0.007) and multivariate analyses (OR: 3.38, 95 % CI: 1.27, 9.31, p = 0.019). The clinical benefit rate on retreatment also showed a marginally significant association with interval time between the two anti-EGFR based therapies (p = 0.053). Median progression-free survival on retreatment was increased in prior responders (4.9 months, 95 % CI: 3.6, 6.2) compared to prior non-responders (2.5 months, 95 % CI, 1.58, 3.42) in univariate (p = 0.064) and multivariate analysis (HR: 0.70, 95 % CI: 0.43-1.15, p = 0.156). CONCLUSION Our data lends support to the concept of clonal evolution, though the clinical impact appears less robust than previously reported. Further work to determine which patients benefit from retreatment post progression is needed.
Collapse
Affiliation(s)
- X Liu
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - G C George
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - A M Tsimberidou
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - A Naing
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - J J Wheler
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - S Kopetz
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit # 426, Houston, TX, 77030, USA.
| | - S Fu
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - S A Piha-Paul
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - C Eng
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit # 426, Houston, TX, 77030, USA.
| | - G S Falchook
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - F Janku
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - C Garrett
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit # 426, Houston, TX, 77030, USA.
| | - D Karp
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - R Kurzrock
- Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San Diego, CA, USA.
| | - R Zinner
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - K Raghav
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit # 426, Houston, TX, 77030, USA.
| | - V Subbiah
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - K Hess
- Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
| | - F Meric-Bernstam
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - D S Hong
- Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
| | - M J Overman
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit # 426, Houston, TX, 77030, USA.
| |
Collapse
|
27
|
Duarte M, Carvalho C, Bernardo S, Barros SV, Benevides S, Flor L, Monteiro M, Marques I, Henriques M, Barros SC, Fagulha T, Ramos F, Luís T, Fevereiro M. Rabbit haemorrhagic disease virus 2 (RHDV2) outbreak in Azores: Disclosure of common genetic markers and phylogenetic segregation within the European strains. INFECTION GENETICS AND EVOLUTION 2015; 35:163-71. [PMID: 26247721 DOI: 10.1016/j.meegid.2015.08.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 04/13/2015] [Revised: 07/28/2015] [Accepted: 08/03/2015] [Indexed: 10/23/2022]
Abstract
Rabbit haemorrhagic disease virus 2 (RHDV2) is widespread in several countries of Western Europe, but it has not been introduced to other continents. However, between late 2014 and early 2015, the presence of RHDV2 was confirmed outside of the European continent, in the Azores, initially in the islands of Graciosa, Flores, S. Jorge and Terceira. In this study we report the subsequent detection of RHDV2 in wild rabbits from the islands of Faial, St. Maria and S. Miguel, and display the necropsy and microscopic examination data obtained, which showed lesions similar to those induced by classical strains of RHDV, with severe affection of lungs and liver. We also disclose the result of a genetic investigation carried out with RHDV2 positive samples from wild rabbits found dead in the seven islands. Partial vp60 sequences were amplified from 27 tissue samples. Nucleotide analysis showed that the Azorean strains are closely related to each other, sharing a high genetic identity (>99.15%). None of the obtained sequences were identical to any RHDV2 sequence publically known, hampering a clue for the source of the outbreaks. However, Bayesian and maximum likelihood phylogenetic analyses disclosed that Azorean strains are more closely related to a few strains from Southern Portugal than with any others presently known. In the analysed region comprising the terminal 942 nucleotides of the vp60 gene, four new single nucleotide polymorphisms (SNP) were identified. Based on the present data, these four SNPs, which are unique in the strains from Azores, may constitute putative molecular geographic markers for Azorean RHDV2 strains, if they persist in the future. One of these variations is a non-synonymous substitution that involves the replacement of one amino acid in a hypervariable region of the capsid protein.
Collapse
Affiliation(s)
- Margarida Duarte
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal.
| | - Carina Carvalho
- Instituto de Ciências Agrárias e Ambientais Mediterrânicas - ICAAM, Universidade de Évora, Núcleo da Mitra, 7000 Évora, Portugal
| | - Susana Bernardo
- Laboratório Regional de Veterinária dos Açores, Vinha Brava 9700-236, Angra do Heroísmo, Azores, Portugal
| | - Sílvia Vanessa Barros
- Laboratório Regional de Veterinária dos Açores, Vinha Brava 9700-236, Angra do Heroísmo, Azores, Portugal
| | - Sandra Benevides
- Laboratório Regional de Veterinária dos Açores, Vinha Brava 9700-236, Angra do Heroísmo, Azores, Portugal
| | - Lídia Flor
- Laboratório Regional de Veterinária dos Açores, Vinha Brava 9700-236, Angra do Heroísmo, Azores, Portugal
| | - Madalena Monteiro
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Pathology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| | - Isabel Marques
- Instituto Gulbenkian de Ciência, Rua da Quinta Grande, 6, 2781-156 Oeiras, Portugal
| | - Margarida Henriques
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| | - Sílvia C Barros
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| | - Teresa Fagulha
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| | - Fernanda Ramos
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| | - Tiago Luís
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| | - Miguel Fevereiro
- Instituto Nacional de Investigação Agrária e Veterinária (INIAV), Virology Laboratory, Rua General Morais Sarmento, 1500-311 Lisbon, Portugal
| |
Collapse
|
28
|
Xu W, Ding J, Xiao C, Li L, Zhuang X, Chen X. Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic. Biomaterials 2015; 54:72-86. [PMID: 25907041 DOI: 10.1016/j.biomaterials.2015.03.021] [Citation(s) in RCA: 129] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2014] [Revised: 02/26/2015] [Accepted: 03/09/2015] [Indexed: 01/08/2023]
|
29
|
Thomas JA. Optical imaging probes for biomolecules: an introductory perspective. Chem Soc Rev 2015; 44:4494-500. [DOI: 10.1039/c5cs00070j] [Citation(s) in RCA: 111] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
An overview of optical biomolecular imaging is provided.
Collapse
Affiliation(s)
- Jim A. Thomas
- Department of Chemistry
- University of Sheffield
- Sheffield
- UK
| |
Collapse
|
30
|
Preethi S, Sivapathasundharam B. Will modified Papanicolaou stain be the new stain for keratin? J Histotechnol 2014. [DOI: 10.1179/2046023614y.0000000053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
31
|
Pandey P, Dixit A, Tanwar A, Sharma A, Mittal S. A comparative study to evaluate liquid dish washing soap as an alternative to xylene and alcohol in deparaffinization and hematoxylin and eosin staining. J Lab Physicians 2014; 6:84-90. [PMID: 25328332 PMCID: PMC4196369 DOI: 10.4103/0974-2727.141504] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
INTRODUCTION Our study presents a new deparaffinizing and hematoxylin and eosin (H and E) staining method that involves the use of easily available, nontoxic and eco-friendly liquid diluted dish washing soap (DWS) by completely eliminating expensive and hazardous xylene and alcohol from deparaffinizing and rehydration prior to staining, staining and from dehydration prior to mounting. The aim was to evaluate and compare the quality of liquid DWS treated xylene and alcohol free (XAF) sections with that of the conventional H and E sections. MATERIALS AND METHODS A total of 100 paraffin embedded tissue blocks from different tissues were included. From each tissue block, one section was stained with conventional H and E (normal sections) and the other with XAF H and E (soapy sections) staining method. Slides were scored using five parameters: Nuclear, cytoplasmic, clarity, uniformity, and crispness of staining. Z-test was used for statistical analysis. RESULTS Soapy sections scored better for cytoplasmic (90%) and crisp staining (95%) with a statistically significant difference. Whereas for uniformity of staining, normal sections (88%) scored over soapy sections (72%) (Z = 2.82, P < 0.05). For nuclear (90%) and clarity of staining (90%) total scored favored soapy sections, but the difference was not statistically significant. About 84% normal sections stained adequately for diagnosis when compared with 86% in soapy sections (Z = 0.396, P > 0.05). CONCLUSION Liquid DWS is a safe and efficient alternative to xylene and alcohol in deparaffinization and routine H and E staining procedure. We are documenting this project that can be used as a model for other histology laboratories.
Collapse
Affiliation(s)
- Pinki Pandey
- Department of Pathology, UP Rural Institute of Medical Sciences and Research, Saifai, Etawah, Uttar Pradesh, India
| | - Alok Dixit
- Department of Pharmacology, UP Rural Institute of Medical Sciences and Research, Saifai, Etawah, Uttar Pradesh, India
| | - Aparna Tanwar
- Department of Pathology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Sultanpur, Kumarhatti, Solan, Himachal Pradesh, India
| | - Anuradha Sharma
- Department of Pathology, M M Institute of Medical Sciences and Research, M M University, Mullana, Ambala, Haryana, India
| | - Sanjeev Mittal
- Department of Pathology, M M Institute of Medical Sciences and Research, M M University, Mullana, Ambala, Haryana, India
| |
Collapse
|
32
|
Bacteriological diagnosis and molecular strain typing of Mycobacterium bovis and Mycobacterium caprae. Res Vet Sci 2014; 97 Suppl:S30-43. [DOI: 10.1016/j.rvsc.2014.04.010] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2013] [Revised: 04/08/2014] [Accepted: 04/24/2014] [Indexed: 11/24/2022]
|
33
|
Liang X, Pei H, Ma L, Ran Y, Chen J, Wang G, Chen L. Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis. Molecules 2014; 19:6163-83. [PMID: 24838072 PMCID: PMC6271706 DOI: 10.3390/molecules19056163] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2014] [Revised: 04/14/2014] [Accepted: 04/15/2014] [Indexed: 02/05/2023] Open
Abstract
Leptin, the product of the obese gene, is an adipocyte-secreted protein hormone playing a key role in the progression of obesity and hepatic steatosis. In this study, 28 novel (thio)urea and guanidine-based analogues have been synthesized and N-(1-(4-(3-(2-chloroethyl)ureido)benzyl)piperidin-4-yl)-3-(trifluoromethyl) benzamide (7i) was found to be a potent regulator of leptin expression in 3T3-L1 adipocytes. Treatment with 7i at a dose of 50 mg/kg/day for 35 days reduced the body weight and liver weight of diet-induced obesity mice by 13.5% and 18.4%, respectively, while also improving the serum levels of triglyceride, total cholesterol, leptin, adiponectin, LDL-c, HDL-c. Hematoxylin-eosin (H&E) and Oil Red O staining also confirmed that 7i ameliorated fat deposition in liver tissue and restricted the size of adipocytes in obesity-related fatty liver disease.
Collapse
Affiliation(s)
- Xiaolin Liang
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| | - Heying Pei
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| | - Liang Ma
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| | - Yan Ran
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| | - Jinying Chen
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| | - Guangcheng Wang
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| | - Lijuan Chen
- State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China.
| |
Collapse
|
34
|
Crockford A, Jamal-Hanjani M, Hicks J, Swanton C. Implications of intratumour heterogeneity for treatment stratification. J Pathol 2014; 232:264-73. [PMID: 24115146 DOI: 10.1002/path.4270] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2013] [Revised: 09/17/2013] [Accepted: 09/18/2013] [Indexed: 12/23/2022]
Abstract
Despite advances in the diagnosis and treatment of cancer, the majority of advanced metastatic solid tumours remain incurable. Differential gene expression, somatic mutational status, tumour-specific genetic signatures and micro-environmental selection pressures within individual tumours have implications for the success of predictive assays to guide therapeutic intervention. In this review we discuss the evidence for genetic and phenotypic heterogeneity and its potential implications for clinical decision making. We highlight areas of research that could be improved in order to better stratify patient treatment. We also discuss the predictive potential of patient-derived models of tumour response, including xenograft and cell line-based systems within the context of intratumour heterogeneity.
Collapse
Affiliation(s)
- Andrew Crockford
- Translational Cancer Therapeutics Laboratory, Cancer Research UK London Research Institute, London, WC2A 3LY, UK
| | | | | | | |
Collapse
|
35
|
Time-Resolved Emission Imaging Microscopy Using Phosphorescent Metal Complexes: Taking FLIM and PLIM to New Lengths. LUMINESCENT AND PHOTOACTIVE TRANSITION METAL COMPLEXES AS BIOMOLECULAR PROBES AND CELLULAR REAGENTS 2014. [DOI: 10.1007/430_2014_168] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
36
|
Riva MA, Manzoni M, Isimbaldi G, Cesana G, Pagni F. Histochemistry: historical development and current use in pathology. Biotech Histochem 2013; 89:81-90. [PMID: 23957702 DOI: 10.3109/10520295.2013.822559] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
We describe the history of the histochemical stains that contributed most to the development of modern pathology during the last two centuries. Histochemical stains are presented in a list, which provides the essential information about year, country and main use of each to enable the reader to follow the chronological and geographical history of histochemistry. In addition to the historical evaluation of histochemistry development, we investigate how many classical histochemical stains survive in a modern laboratory of pathology and how often they are used for diagnostic practice compared to immunohistochemical (IHC) techniques. A ratio of about one histochemical reaction to 13 IHC reactions was tabulated. Finally, our data make it possible to define different cultural approaches to the terminology of histochemical and IHC stains: the former were based on eponyms, which link the stain with the name of its inventor, while the latter use a more impersonal biological terminology.
Collapse
Affiliation(s)
- M A Riva
- Section of History of Medicine, Research Centre on Public Health
| | | | | | | | | |
Collapse
|
37
|
Historical perspectives on myelodysplastic syndromes. Leuk Res 2012; 36:1441-52. [PMID: 22921019 DOI: 10.1016/j.leukres.2012.08.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Revised: 08/01/2012] [Accepted: 08/06/2012] [Indexed: 11/22/2022]
|
38
|
Onul A, Colvard MD, Paradise WA, Elseth KM, Vesper BJ, Gouvas E, Deliu Z, Garcia KD, Pestle WJ, Radosevich JA. Application of immunohistochemical staining to detect antigen destruction as a measure of tissue damage. J Histochem Cytochem 2012; 60:683-93. [PMID: 22723525 DOI: 10.1369/0022155412452146] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Electrocautery and directed energy devices (DEDs) such as lasers, which are used in surgery, result in tissue damage that cannot be readily detected by traditional histological methods, such as hematoxylin and eosin staining. Alternative staining methods, including 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to stain live tissue, have been reported. Despite providing superior detection of damaged tissue relative to the hematoxylin and eosin (H&E) method, the MTT method possesses a number of drawbacks, most notably that it must be carried out on live tissue samples. Herein, we report the development of a novel staining method, "antigen destruction immunohistochemistry" (ADI), which can be carried out on paraffin-embedded tissue. The ADI method takes advantage of epitope loss to define the area of tissue damage and provides many of the benefits of live tissue MTT staining without the drawbacks inherent to that method. In addition, the authors provide data to support the use of antibodies directed at a number of gene products for use in animal tissue for which there are no species-specific antibodies commercially available, as well as an example of a species-specific direct antibody. Data are provided that support the use of this method in many tissue models, as well as evidence that ADI is comparable to the live tissue MTT method.
Collapse
Affiliation(s)
- Abdullah Onul
- Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, Chicago, IL 60612, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
History of cancer disease models clearly illustrates the evolving nature of these concepts. Since such models undergo continual revisions and additions as a result of underlying medical research, they also tend to reorganize knowledge and allow perceiving previously unseen relationships. Growth of medical thought has been influenced for many centuries by an ancient Hippocratic concept of disease seen as a disturbance in bodily “humors.” True mechanisms of cell and tissue injury started to be elucidated only with the advent of postmortem pathological findings. Concerning cancer, when first disease-producing bacteria were identified in the nineteenth century, also neoplasms were treated as infectious diseases. Foreign organisms were thought to be present inside tumors. However, this hypothesis could not be confirmed by microscopic or histochemical studies. The latter suggested, instead, that tumors were rather formed by abnormal cells. Cancer was then started to be regarded as a disease of cells. This interpretation was radically altered by later developments in genetics which suggested that neoplasms can be treated as genetic diseases as pathologic cellular lesions are caused by mutations in specific genes. More recent models have compared carcinogenesis to evolutionary processes. Due to genetic instability, successive mutations, appearing in cells, lead to selection of cancer cells which feature specific phenotypic traits. The newest data indicate that there may be also a link between cancer and mutated stem cells. The review discusses main concepts of tumor origin forwarded since the beginnings of the nineteenth century.
Collapse
|
40
|
Józsa L. [The history of microscopic stains]. Orv Hetil 2010; 151:752-4. [PMID: 20410003 DOI: 10.1556/oh.2010.ho2293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|